Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00131378
Status:
COMPLETED
Last Update Posted:
2016-03-11
First Post:
2005-08-16
Brief Title:
Growth Hormone Cardiovascular Risk and Visceral Adiposity
Sponsor:
Massachusetts General Hospital
Organization:
Massachusetts General Hospital
Study Overview
Official Title:
Growth Hormone Cardiovascular Risk and Visceral Adiposity
Status:
COMPLETED
Status Verified Date:
2016-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will compare growth hormone levels and cardiovascular risk markers in normal weight and overweight women and men In women and men with increased abdominal weight growth hormone GH versus placebo will be administered and effects on cardiovascular risk insulin resistance and body composition will be measured
Detailed Description:
The purpose of this study is to measure growth hormone levels in women and men who are normal weight overweight and obese Growth hormone levels will be correlated with body weight body composition and markers of cardiovascular risk In overweight or obese women and men with increased visceral adiposity and below average IGF-1 levels growth hormone versus placebo will be given for 6 months Effects of growth hormone treatment on weight body composition insulin resistance lipids and cardiovascular risk markers will then be assessed Study subjects will be followed for an additional six months for these endpoints
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R01HL077674 | NIH | None | httpsreporternihgovquickSearchR01HL077674 |
| MGH GCRC 678 | None | None | None |
| 2004-P-000013 | None | None | None |